▁neurologic
32
till
▁35%
insulin
▁unilateral
romes
oneph
ipr
▁muc
trum
▁suppor
-2)
▁artery
▁symptomatic
▁smo
▁nonspecific
taz
▁gels
▁functionally
▁satis
▁pate
Ig
▁cancers
7,
erent
epithelial
tially
▁30%
▁controver
ulla
atif
.2
▁cardiac
▁objec
anine
loxacin
▁(30
oprotein
▁perfusion
ifed
ichia
lip
▁decreases
orac
iae
▁noc
▁tas
▁diarrhea
entral
pecially
-8
plas
5),
▁excretion
▁throm
alian
▁comprised
▁clus
▁cerv
usate
▁mU
chloride
▁angina
▁gonadotropin
esic
▁prolactin
▁comple
lys
erence
▁succin
▁enamel
▁acute
▁heparin
fec
▁glomerular
▁intravenous
▁cartilage
▁instrum
▁erythrocyte
amycin
venty
▁deviation
versely
▁prostaglandin
-19
roscop
4)
▁(9
▁sulf
ture
▁4.4
▁6%
BH
pecific
▁effec
▁rupture
▁ECG
▁198
▁(14
▁indications
formations
▁impaired
▁satur
pig
▁examinations
▁ultras
▁triglycerides
▁responsiveness
▁7-
▁interferon
ovascular
trial
▁cephal
▁scre
▁Leu
▁quantitative
▁lact
▁underg
23
luding
robial
occal
▁stren
rosemide
ocl
inally
reased
▁15-
▁acqui
▁unchanged
tero
▁suppres
▁histological
ectomy
april
ionine
▁vitro
tracted
▁intub
▁uter
encephal
▁inhibitor
▁Thirty
ureus
▁quanti
astric
▁vein
▁9,
tig
ipro
▁regurgitation
tally
▁0.4
▁85
▁heterogene
▁gestation
▁cann
teroids
▁pancre
idation
▁200
5%
▁3-
-7
8).
trover
geal
rometry
▁Ig
▁decarbox
▁bicarbonate
▁uro
adrenergic
▁steroids
oag
ifferen
▁potassium
▁randomized
▁4.
▁Americ
▁intraven
▁12%
▁6.5
pine
▁(0
▁2.8
▁fluc
▁hazard
▁urinary
ophil
▁potent
onomic
sively
▁subjec
▁dihydro
▁Increas
▁suscepti
Pa
teroid
▁graf
coated
timulation
▁sepsis
▁venti
▁superficial
thi
erative
▁incub
▁cartil
88
ximum
/1
ostic
tice
▁exten
/3
owever
▁latency
▁thre
▁electrodes
▁60%
▁morphine
▁HPV
absorption
ffe
acil
▁systemic
▁zinc
otroph
▁markers
▁10
irc
okine
ergen
▁hyperg
atitis
▁69
▁limb
▁canc
bladder
idne
▁(24
▁compli
▁beats
▁memb
-15
risk
2/
▁anemia
azole
oglobin
▁treadmill
uting
▁inten
enteric
ariate
▁electroly
▁(7
▁strains
▁hydrochloride
ograms
▁resec
▁optimum
▁1.2
▁drin
▁prophylaxis
oluble
▁rhe
estis
▁contamin
fib
▁enti
▁differe
ymptomatic
▁carriers
BV
▁Clinical
▁cyt
din
▁pelvic
▁61
tran
▁inhibitors
▁incomplete
▁congenital
▁affinities
tingu
rox
▁exer
▁relapse
▁antiarrhythmic
loid
aminop
▁hypertensive
4),
▁impairment
▁dissemin
tured
onyl
▁severity
6.
▁prenatal
iatric
▁soy
tics
▁RA
duction
duced
▁leukotriene
ayers
▁saturated
DNA
▁ech
tiz
▁deficiency
▁skeletal
25
▁abnormalities
scherichia
▁intermittent
2%
▁71
▁45
vation
▁0.5
▁estradiol
33
▁inver
etan
▁assay
▁premature
▁Bac
phic
acted
▁disturbances
onstric
▁casein
▁EG
thma
ignific
▁86
▁ect
▁recom
▁bac
ypical
▁unstable
anking
yrox
▁indicators
stimulating
▁(3)
26
500
rhy
piration
▁acces
▁40
▁capillary
illus
GH
▁HSV
▁fetal
▁enal
▁1
▁prognosis
-13
▁cavity
ethyl
▁percentages
throm
gely
▁ovarian
▁prophyl
▁untreated
xia
▁attenu
-1).
▁retard
▁shorten
47
esity
▁receptor
▁persisted
aryn
0-
▁68
stim
▁responsive
illin
trates
osts
▁adequ
olec
cyclic
acid
assi
▁bilateral
LH
cholesterol
▁lep
▁neph
opausal
▁twofold
▁bilirubin
▁12
erance
95
osterone
istar
▁2,
▁decreased
▁respec
▁thi
adic
zymes
▁toxicity
▁defec
▁ket
sies
.6%
▁intra
ulant
illary
▁perin
▁reticul
otoxicity
ipramine
7-
▁bip
sulf
reas
▁challen
▁proce
.7
5%)
10
▁poten
▁ultim
▁quantified
opamine
▁wee
sA
▁homogeneity
▁32
mature
oretic
2,
openia
▁behavioral
▁metabolic
▁affec
▁20%
▁ejection
▁onset
▁5.0
olytic
-18
49
directed
immun
▁concurrent
▁posi
▁12,
▁30-
▁70
▁20
▁substanti
terol
▁criter
cribed
▁intramuscular
leu
dial
mia
▁shor
▁precursors
terone
▁cardiovascular
▁4
▁elevated
▁measurable
▁adap
▁reas
timal
osomal
ocin
▁cranial
-2.
7%
▁occupational
tation
▁enlarge
▁arterial
▁metastatic
7).
monary
▁secreted
-5
▁spon
▁horiz
tec
▁diabetic
▁inadequate
▁underwent
ept
▁mann
▁aspartate
▁8.
▁viral
dered
▁prospective
▁generalized
▁10,
3),
treatment
▁Compared
yel
▁bir
-12
hyd
▁administered
28
▁0.04
▁averaged
-1
▁Treatment
▁recipients
roph
▁panc
rosis
ycin
▁ventilation
▁glycos
▁attributable
eded
▁leuk
OH
.0
▁transferrin
▁concomitant
▁hemat
▁progression
3)
▁aspec
osin
▁hemorrhage
▁(50
▁Forty
▁enhances
▁guinea
▁normotensive
▁49
▁25%
▁predictive
▁52
▁110
▁94
▁microscopic
▁complication
tic
▁mmol
▁Sixty
rowth
certain
otoxic
▁sero
piratory
▁amin
▁adren
aryngeal
▁emerg
▁MRI
rease
tinu
Ca
▁correlate
▁sten
▁35
usp
lobulin
tis
▁reflec
▁psychiatric
ameth
▁vasoconstric
▁placental
▁maternal
▁inhal
7)
dia
tine
luded
vice
ospitals
▁2.7
lyl
▁injur
▁evaluating
plants
▁angiography
▁dox
1),
▁judged
▁15,
▁offspring
-20
ogenic
▁predis
protein
▁oste
▁duplex
▁hypo
▁electr
-1)
▁initiation
▁intram
bacco
▁repro
▁immunization
topril
otox
6)
adder
▁exhibited
▁synthesized
▁antibiotic
ospor
▁(0.
▁25-
▁symp
3.
▁3.8
-24
ipine
▁8%
▁Alz
▁41
▁pla
0%)
opathy
▁hemo
tel
▁benign
▁excised
▁Significant
ereb
▁fatty
▁progesterone
▁93
▁perox
amines
ocortic
ilep
oderm
65
▁1.6
ylase
▁lesion
▁elevation
tance
ophag
eces
▁0.25
▁encephal
6,
▁transfusion
▁excision
inic
centr
▁leukotri
▁43
▁fluoride
▁valu
▁105
▁identi
▁subsets
cyt
odiaz
▁extrac
▁obstruction
imens
urgical
▁anomal
75
osom
▁pneumon
(1
duce
▁imaging
uminal
.3%
asone
bly
▁ablation
entif
▁clamp
tus
▁fluids
▁insulin
▁sequenced
▁pep
terase
▁efficacy
▁600
▁6.
olamine
.8
▁fetuses
9).
▁extre
omycin
▁ulcer
▁nig
▁deli
▁urine
▁0.05
▁contracep
yridine
amel
▁foc
▁0.2
tual
▁captopril
▁discon
positive
▁supple
▁lesions
▁hypog
▁65
▁resection
▁conjunction
▁prospectively
3-
▁infar
9,
▁100-
elves
▁systolic
▁ingestion
owel
▁substantially
▁3.6
▁pulses
▁tuberculosis
ritin
.9
▁thrombosis
.0%
▁balloon
tomy
restricted
▁granul
▁auditory
lysis
adian
▁triglycer
▁attrib
itus
gthen
▁asymptomatic
sors
▁attenuation
▁parental
▁questionnai
coun
amphen
genic
uncture
▁hypers
pregn
▁comparative
▁converting
▁Meas
▁immun
controlled
13
9%)
▁3%
ergency
orption
▁mortality
▁inadequ
▁invasive
▁peritoneal
▁suppression
▁elic
▁wk
▁28
▁4)
▁pancreatitis
ophys
hetamine
LDL
▁soluble
aminase
▁7.5
▁dex
ficial
▁digoxin
acr
▁100
▁reactivity
-14
▁gluc
▁cytochrome
ighted
▁thromb
▁130
▁3,
▁rup
esti
▁coated
▁brainstem
▁increas
▁fibrillation
▁intrap
▁TS
ventricular
▁21
▁retinal
oxic
cessive
▁evid
▁endometrial
27
▁2.2
▁9-
▁repres
estion
▁immunized
▁derm
▁PV
▁pati
▁cyst
▁kidney
tive
▁sediment
patients
sion
▁1990
1-
ergic
ration
▁quantif
▁regression
▁atrophy
traction
trogen
enicillin
▁74
▁inhibitory
▁1.0
urine
▁differed
▁focal
igaret
▁3.3
▁glands
vely
8)
sectional
.4%
▁lith
▁mell
▁placebo
rogenic
▁cyclospor
39
clin
▁intrac
crib
▁pretreatment
▁blocker
bodies
DH
▁antagon
▁investigations
▁newborn
▁gradual
osamine
▁ovulation
▁differentiate
▁2%
▁pH
-16
tively
▁biochemical
ropathy
1%)
▁42
▁normo
▁rats
▁tes
tein
▁supplementation
mL
▁obesity
▁fatigue
▁ester
▁cardi
lyc
chol
8,
ionic
▁0
▁acutely
▁adip
▁angi
▁arthritis
▁leakage
▁lavage
vascular
▁83
ucose
▁opioid
uted
irubin
▁gonad
sistent
▁LD
▁lowering
▁(6
▁spor
vic
phen
onc
▁familial
teral
▁econ
▁glomerul
▁practic
atation
rele
▁surgical
▁fixation
scher
▁discus
▁plas
oplasm
▁colonic
▁veins
▁hydrox
▁IgA
▁pretreated
mental
tensive
20
osus
▁pertussis
▁reac
quine
oyl
tussis
▁ultrasound
▁6
▁contrib
ocytes
▁obstructive
ctive
turb
omethacin
▁77
orectal
ranolol
▁hypox
tivities
▁lumen
tivity
uppression
▁CG
iotics
▁7.2
inemia
▁linearly
▁seroton
hydrox
hep
▁2.3
▁inspiratory
trol
▁7,
ochem
▁calcium
▁prevalence
▁consecu
▁10.
▁androgen
▁predic
▁saturation
▁struc
▁extracts
resist
ogenicity
%).
ochemical
tiv
▁45%
tage
ocytosis
▁infusions
▁experimentally
▁gestational
▁melanoma
▁indomethacin
▁uncom
orrh
ocardi
▁38
▁48
▁supplemented
2),
▁89
▁cutaneous
▁insufficiency
▁brom
▁HB
operatively
▁alcoh
viron
▁reduc
▁infections
▁remission
ithelial
▁recordings
amuscular
keletal
▁definite
▁reversible
▁morbidity
▁HL
▁Hyper
ogl
▁creatinine
▁arth
▁differing
ithi
▁physici
▁hyperthyroid
▁atten
tically
▁fas
▁histology
▁decreasing
▁propranolol
▁penicillin
▁82
▁synovial
▁identif
▁variability
▁exceeded
▁recor
▁66
▁excre
oxid
▁secrete
lusion
▁6.2
▁Hyp
oglobulin
tical
athyroid
▁favorable
▁surgically
ophy
▁46
▁(21
amus
▁lipoprotein
3%
arbox
▁plasminogen
▁adverse
hydrop
80
▁bronchial
ints
mittent
▁4.6
▁thir
▁remo
▁7
ocellular
▁amplification
▁colorectal
tious
arrhy
onucle
45
pH
6).
drug
ulose
▁progres
▁bacterial
▁bran
▁vitamin
▁dilatation
otassium
▁cis
▁hypotension
▁expressing
▁spontaneous
60
tures
lobin
hydroxyp
▁reser
▁physicians
hea
▁197
▁tumor
erated
dominal
itamin
▁toge
▁95
▁induction
aturated
iability
▁substitution
▁aerobic
aicin
omized
queous
▁90%
▁isch
odium
.8%
▁capsaicin
▁peripheral
▁abor
uresis
TG
▁gradi
▁antagonist
exposed
▁6-
▁consis
▁substances
000
▁coli
idase
▁infarct
:1
gic
▁methyl
▁NP
▁1986
▁hyperp
▁paren
▁(2
▁calor
▁84
kely
accharide
▁latent
osyl
▁Afric
ocardial
tives
▁phenyl
▁2.0
angl
ortic
albumin
▁sedimentation
▁Addition
2).
▁30
▁infec
▁(1
▁(12
▁-1
▁carotid
antial
▁angioplasty
▁0.15
▁histopath
▁prognostic
▁transi
crip
▁contex
versity
▁actin
▁vaccination
pir
oxin
▁Whereas
▁2.1
▁0.06
▁pigment
ffinities
iol
dition
greater
eared
▁(15
▁Neu
associated
11
-60
35
otypes
▁Doppler
30
▁menstr
▁agon
▁insertion
▁immunoglobulin
▁81
▁glucocorticoid
▁LT
▁oxytocin
itant
Hg
▁examin
▁Bec
▁schiz
NH
ymptom
▁parathyroid
xate
-100
▁selec
▁inducing
▁adop
▁injec
▁infectious
▁deficit
▁cholesterol
▁theore
▁enzymes
▁gon
▁hydrogen
3%)
▁chan
vity
▁clon
▁cryp
▁urea
jected
phal
▁3.9
▁preparations
trical
▁1989
▁nonc
5-
▁allergic
▁16
▁markedly
▁pituitary
▁80%
▁3.0
▁dors
▁(0.0
oscopy
▁progn
▁5.4
▁operative
▁1987
▁etiology
leukin
ults
eration
▁MIC
▁mucosa
▁hemorrh
▁protoc
▁(20
▁alcoholic
▁44
100
▁diets
utions
▁22
▁infusion
▁chor
▁chlor
▁reactive
▁(10
▁immunosorbent
▁demonstrates
43
▁inflammation
plasia
▁300
▁lipid
▁ineffective
▁lipids
▁15%
▁140
kine
▁cortic
▁unclear
▁enzyme
▁chemically
79
gesterone
fusion
meth
intestinal
▁FEV
azol
▁ischemic
▁molecule
▁compart
▁carbohydrate
amide
iasis
4%
▁recr
▁doses
▁inflammatory
▁99
▁4.2
onin
▁(100
▁yeast
amphenicol
▁0.6
▁developmental
▁(8
▁benz
▁TC
responsive
▁asthmatic
▁prednis
▁dimethyl
15
▁rheumatoid
obl
▁donors
idated
▁conduc
85
▁ascorb
avail
▁spinal
▁indi
invasive
▁postnatal
9%
acetic
omotor
▁65%
▁59
ucle
bic
▁retic
▁vesicle
▁preceding
▁lumb
▁duc
bacter
athy
▁elimination
urys
▁anaerobic
tur
trated
▁transient
ensi
5).
▁cerebral
▁renin
▁hepatic
▁regimen
odal
hydro
▁DF
immune
▁incom
LV
▁exce
▁fractures
▁arrhythmias
▁viruses
▁trig
uria
▁eti
▁elec
▁dysfunction
lier
▁ratios
cence
▁rheum
▁serum
anol
2-
▁7%
▁refractory
▁Subjects
▁methionine
aemic
tituted
ifedipine
▁infants
▁blot
.6
▁analyses
24
▁ure
▁cen
▁discharge
▁echocardi
▁Hb
▁obese
▁39
▁Staphylococcus
▁transverse
achol
▁endocrine
lym
olesterol
▁nephropathy
▁57
▁restric
etal
▁infarction
▁underst
oracic
.7%
▁analges
▁elevations
▁subc
▁predicting
▁cysts
atible
▁80
▁0.01).
tisone
icep
ritis
HB
▁neon
▁hypothal
▁1985
▁recurrent
▁acids
▁intest
▁differenti
▁congen
▁acetyl
vents
lact
▁calcitonin
▁(16
▁magnesium
ochrome
▁elimin
▁0.01
▁subgroup
▁73
▁hemoglobin
▁exposures
bumin
▁termination
-1.
▁respiratory
▁oxy
▁tric
▁expres
lec
aline
ditions
▁analogue
▁92
bral
▁concentrations
▁anticoag
▁induce
▁ane
▁cef
▁accounted
tiveness
▁25
lycemia
▁kinase
▁malign
▁biopsy
▁sugges
▁13-
toxic
▁filtration
▁studi
▁reflecting
▁tomography
▁deposition
▁acetate
▁Measure
adily
1)
70
ucl
▁salivary
ceptive
▁(11
tric
thmias
qui
▁bowel
▁LDL
oprol
-9
▁supra
▁assessed
ctomy
tors
▁unrelated
▁88
lycer
apamil
▁accep
▁smokers
▁statis
▁direc
ocys
ordance
avage
6-
▁outflow
▁thrombo
LISA
▁ori
regulation
▁construc
▁bypass
ensitivity
▁1.8
atients
▁paired
ffeine
tration
▁distal
▁ulc
▁nicot
55
▁Hep
▁injections
▁2
▁vaccin
▁ocular
▁(18
tensin
▁comparisons
▁asthma
▁mL
▁deoxy
ximal
▁lute
quisition
▁ventricular
ofl
▁regulate
▁testicular
4).
opres
ranial
8.
flamm
▁(3
▁19
▁nicotine
/2
▁hypertension
urea
leb
▁51
tents
mol
▁venous
otropin
▁97
1.
▁perc
▁undergo
▁endoscop
▁duoden
▁aqueous
▁Twelve
▁IU
▁susceptibility
otting
/6
▁intensive
inflammatory
oxide
atum
ocyte
▁multic
▁fung
-4
1,
.5%
▁choline
▁standardized
irub
▁transplant
▁4.8
renal
▁weakly
▁ach
▁bladder
▁implants
▁67
tact
reast
clic
sych
ostatic
▁summ
▁fibr
oidal
spective
▁bloc
▁ranged
tioned
▁glycol
iotensin
▁plasmin
ilization
2.
▁idiopathic
▁50
▁antibodies
▁interleukin
▁previ
thmatic
▁dysplasia
tox
▁amp
▁carbohyd
▁epidemi
ethylene
▁simult
▁chol
▁diastolic
▁relap
limb
14
▁residual
▁0.1
▁conges
▁26
assium
▁pharmacokinetic
▁presumed
acet
▁limbs
feron
%),
▁detec
anad
▁occurrence
ecal
4-
▁contractions
0.5
▁valve
▁verapamil
▁decreas
▁squamous
onine
▁2-
-10
▁percutaneous
▁iso
-3
armac
▁neonatal
▁inflamm
34
▁splen
▁numb
▁12-
▁hypoxic
▁ulcers
taining
zard
ffin
erin
HDL
▁tach
radi
▁coag
▁120
▁simplex
reactive
coh
▁cruc
ilic
▁fibrosis
▁specificity
▁4-
acrine
▁inges
▁histamine
dine
▁neutroph
acting
▁gastro
▁acet
EG
▁acidic
▁34
▁HLA
▁retur
▁4%
▁capsule
▁successive
▁glycoprotein
▁enl
▁retardation
7%)
▁biop
▁testis
▁hypothalamic
▁lutein
titis
ticular
lyce
▁atropine
tum
▁blockers
▁(4
▁ischemia
erb
organic
▁polyp
trac
▁esophageal
▁thereafter
▁inversely
▁depres
4%)
ophilic
ulatory
▁trac
▁peri
▁sampl
▁osmotic
actin
diabetic
gth
▁dopamine
▁demonstrating
▁tran
▁lymphocytes
tent
▁fracture
▁defic
▁bronch
inergic
▁correlates
▁contraction
▁multiv
▁kinases
▁(4)
▁dosing
titution
▁intake
▁cystic
▁stu
▁sple
▁saliv
▁alanine
▁nodules
▁effic
2;
hyp
odon
▁anesthetic
4,
anding
hypertensive
▁proximal
▁1.1
▁disturbance
▁predominant
▁hypertrophy
rine
▁luteal
▁hepat
▁15
▁confir
orbent
echn
ophren
echan
dle
▁arteri
▁0.0
▁Calc
5)
▁sci
opus
tural
▁(25
opa
▁0.03
▁caffeine
gluc
▁coh
▁leukocyte
▁vaginal
56
▁87
▁embry
went
▁myc
▁drainage
▁postoperatively
▁persis
omat
▁pneumonia
99
itin
spectively
▁intermedi
▁bolus
▁pyr
▁TP
rologic
onary
16
▁predominantly
illar
▁thresholds
▁hepatocellular
▁Hear
▁statistically
reactivity
eak
iminary
▁monit
prising
oconstric
deficient
▁propor
▁anat
▁hyperplasia
tisol
▁retention
,000
▁allergen
▁chronically
.4
▁11
Rs
▁antagonists
cine
▁tubercul
▁3.4
▁coronary
▁selective
▁20.
▁Tran
▁postoperative
vitamin
▁3.1
▁95%
▁carcinoma
▁-0.
▁hydroly
▁detecting
▁antigen
gment
▁experim
▁diffic
▁pec
opro
▁beha
▁atypical
.1
▁ppm
ergy
yrid
ecu
▁nasal
▁3.
▁bic
▁herpes
atoid
▁irregular
▁Subjec
▁antic
▁33
▁24
▁junction
ophageal
arate
enzyme
mediately
▁diminished
▁longitudinal
▁omega
erating
1/
▁fasting
▁differen
▁inh
▁hypothe
▁50%
nine
▁0.00
▁induc
▁29
trin
▁unaffected
▁deterioration
loro
▁(95%
▁diagnoses
epam
▁27
itonin
▁duodenal
.1%
▁dietary
▁fractions
yroid
▁5%
▁subjective
epti
umerous
▁albumin
asal
embran
ovirus
ogens
odil
▁glomer
enic
-80
▁98
▁expiratory
▁1:
▁proton
▁antibody
▁Patients
▁usefulness
▁esophag
ronch
NB
▁dosage
▁polym
▁congestive
▁4.3
▁perip
hydr
▁hypoth
▁resonance
osal
▁plateau
▁-2
▁quantit
▁compartments
▁mono
▁pathology
▁glucocortic
2%)
erebral
atient
tens
▁Nine
0.0
▁cros
▁carcinomas
0,
▁inser
▁Serum
tory
▁pharmac
▁exis
▁characteris
amicin
▁20-
sibly
▁synthesize
brom
▁cyclosporine
▁75%
sess
feren
ocrine
▁5-
methyl
▁discontinu
cepti
▁96
peptide
▁ow
utaneous
▁peroxide
▁glut
▁cereb
itone
rein
▁analgesia
▁titers
▁assessing
▁0.7
9)
▁produc
▁interc
menopausal
▁dexamethasone
▁symptom
▁prostatic
viral
ectin
▁3.7
alc
▁24-
▁melan
▁techniqu
▁basal
median
▁clonidine
▁5
▁arti
▁morb
▁creatine
arial
▁ambulatory
17
▁undergoing
▁enalapril
▁repor
▁1.3
▁nitrogen
▁carcin
0.
ographically
▁250
▁influenza
quid
plemented
ectom
▁femoral
▁arter
▁advan
▁5,
enal
▁thyroid
iloride
▁provid
▁150
▁PCR
ocar
▁traum
estions
ocor
trop
essation
▁qualit
8%
▁activator
▁qualitative
▁subgroups
▁stimulation
vul
▁tib
▁prol
wes
tained
otri
▁Increased
▁196
▁amo
▁14
▁estrogen
tro
ylic
▁1)
▁requi
▁mitral
induced
▁adenocarcinoma
partate
▁postin
▁impair
admill
arrhythmic
36
▁conductance
▁airway
olone
ogenous
produc
▁lumbar
▁199
▁uptake
▁sodium
8%)
▁Initi
▁pediatric
▁ventil
▁chemotherapy
icin
uric
roscopic
▁implicated
▁inhibit
venous
▁Fifty
cious
▁abdominal
▁plasm
▁(22
▁160
▁hypot
90
▁31
onography
▁40%
▁60
▁adherence
▁dorsal
tial
▁lar
▁5)
hion
▁metabolism
sions
thyl
jec
▁histologic
▁aspirin
▁moderately
▁2.9
▁sham
▁LV
▁edema
▁63
asic
floxacin
▁1000
▁Comparison
0%
▁malignancy
-25
nai
flammatory
▁verte
▁5.
▁resistant
thmic
▁neutrophil
▁proteinuria
▁ae
0,000
▁influenz
entical
ocaine
▁preoperative
0)
▁hepatitis
lytic
otrexate
▁gland
▁microscop
▁abnormal
▁orally
▁regimens
▁7.
▁pathologic
▁retrospective
▁atrial
ociation
▁defects
-50
▁reflux
tility
uretic
▁4.5
4.
-2
▁nifedipine
bility
otyp
▁specificities
idespread
▁1.5
operative
▁pancreatic
gative
▁hypothyroid
▁37
.9%
▁3)
▁lymph
ignificant
3,
-6
▁mice
▁reproductive
▁compartment
▁unex
▁10%
▁5.6
▁8-
acchar
▁1%
aric
▁erg
▁commerc
ontal
▁0.9
21
acin
▁chloride
▁metast
▁undergone
▁pressures
37
▁mening
generation
partum
▁conditioning
▁exhibiting
olated
▁epidural
opathic
phil
releasing
▁thems
▁decarboxylase
imin
▁reflex
▁differentiated
7.
ymp
▁heterogeneity
lob
-17
▁possi
▁tended
.5
▁interf
▁agonist
bearing
▁tolerated
▁uterus
▁clinically
▁ferritin
ffec
idin
sive
yste
ocyt
▁graft
tension
▁intrav
▁tiss
▁55
▁kidne
▁adenomas
▁manifestations
▁regurg
-5)
2)
tention
▁questionnaire
idine
6%
▁cumulative
▁precur
▁localized
▁scans
epine
▁54
romy
▁phosphate
phosph
veness
▁cervical
▁receptive
86
.2%
▁62
▁diazepam
▁1.
▁17
▁500
▁tumors
ylated
itro
▁lateral
▁metastases
ardia
▁probes
▁therapeutic
19
▁EB
rates
▁IgM
▁nutritional
esium
▁avail
sia
lated
▁assays
idate
▁angiotensin
thyroid
ilateral
▁cytoch
uscular
▁malignant
38
▁compounds
enia
▁53
▁chec
▁retin
▁23
▁membran
▁(2)
1%
▁3.2
oscop
▁adrenal
▁epidemiological
oplasty
▁immunos
arbonate
/10
▁sti
▁0.
▁reductions
Cs
▁90
aturation
▁Evidence
▁2.5
▁10-
icillin
1).
odies
urther
▁micros
▁pneum
▁resul
otor
▁promin
▁aureus
lox
66
▁(0.5
▁allele
▁IgG
respective
rected
▁graded
▁nitro
illi
thmia
▁elastic
▁2.6
otrop
▁400
ayed
▁monitored
▁2.
iotic
▁aden
unctional
▁(17
tron
otre
▁vascular
▁56
inesterase
▁2.4
▁-3
▁Thy
▁79
▁glucose
ociated
erad
mentation
▁stimul
▁76
▁lactation
natal
▁PCO
▁steroid
▁endogenous
▁abnormality
▁HDL
apanese
opo
▁uterine
▁CI
▁cultured
emia
▁glyc
▁subcutaneous
▁biphasic
▁esters
▁agonists
nec
orpor
▁gastric
▁screened
▁1,
amethasone
▁1-
effec
▁immunobl
▁splenic
▁cortisol
▁20,
lux
22
▁transcription
vian
elec
▁incidence
▁somatic
▁5.5
▁6,
utable
▁anesthesia
▁stimulus
▁plaques
▁citrate
50
sible
▁RR
▁islet
▁adjustment
▁antibiotics
▁deterior
containing
▁duct
▁5.2
▁pharmacokine
treated
00
▁isolates
▁scanning
motic
▁cessation
▁autoimmune
▁3.5
omal
▁9
▁4.0
▁placenta
tinguish
olol
▁combin
▁14,
toc
▁intestinal
▁diabe
▁fetus
▁pregnancies
▁18
▁70%
▁8
affec
icine
▁reproduc
▁myocardial
zyme
resistant
▁91
▁reversed
astolic
tative
18
▁amph
▁yielded
5,
seud
rents
▁diaz
▁calf
44
▁125
▁regulating
▁ligation
▁stenosis
▁simultaneous
▁rectal
tition
ipit
▁58
/100
▁sulfate
53
▁13
5.
posure
▁cys
▁assis
tral
oic
▁rhy
▁devi
▁mellitus
retin
ositi
▁rati
▁quin
▁proportions
▁dissection
rocy
tions
▁renal
▁1.7
▁75
olism
vices
ocomp
▁fati
▁100%
▁pyl
▁0.02
▁72
adequ
▁hetero
▁cate
mega
urrent
eric
▁ana
▁correlated
ygen
▁kidneys
blind
▁dehyd
▁dye
▁establ
trib
▁hormone
▁membranes
▁3
▁immunity
▁testosterone
▁detectable
▁positively
▁64
▁tox
▁amn
uble
▁1.4
dose
▁neurotrans
▁neonates
adm
chlor
▁prolonged
oride
oxygen
eptide
molecular
▁cohort
lood
▁obser
▁(1)
adren
ometh
▁adi
yro
▁minus
▁injected
57
ducing
▁0.3
▁coagulation
▁47
▁(40
40
▁pleural
12
▁multivariate
▁bacteri
entricular
▁polyc
▁amiloride
▁intracranial
▁potenti
▁1/
▁neurop
▁autoantibodies
onate
48
▁Escherichia
▁vesicles
▁Thir
▁lidocaine
▁biopsies
▁ery
▁0.8
▁4.1
▁(19
▁eryth
▁Insulin
▁frac
▁physiological
▁methotrexate
ologic
jun
erate
▁Hg
itrate
31
gia
▁attemp
selec
▁indus
▁hep
▁85%
▁suppressed
mented
tin
▁recurrence
bac
▁(5
▁phosph
scop
▁triglyceride
orec
tif
▁preven
▁cyclo
▁receptors
▁TSH
▁phenotype
▁concom
▁mobilization
▁spre
romycin
mend
▁hypertro
tional
idazole
siveness
▁sensi
▁36
3).
29
450
▁complications
000.
▁ELISA
8-
yroxine
micro
▁nec
tion
molec
▁pulmonary
▁reproducible
6%)
.3
olysis
agic
olus
▁1.9
▁stric
▁78
▁2)
sibility
tivation
